Evidence map›Paper›PMID 19880521›Full record

ArticleThe Journal of biological chemistry2010

Identification of a functional network of human epigenetic silencing factors.

Andrey Poleshko, Margret B Einarson, Natalia Shalginskikh, Rugang Zhang, Peter D Adams, Anna Marie Skalka, Richard A Katz

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrey PoleshkoInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Margret B Einarson
Natalia Shalginskikh
Rugang Zhang
Peter D Adams
Anna Marie Skalka
Richard A Katz
Fox Chase Cancer Center · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
INTEGRATION OF RETROVIRAL DNA--ACCESSING HOST TARGET DNAR01CA071515 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KATZ, RICHARD ALAN · 1996 to 2016
$7.6M
STRUCTURE/FUNCTION OF INTEGRASER01AI040385 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI ANDRAKE, MARK DAVID · 1997 to 2016
$7.1M
Discovery of Epigenetic Marks in Human Cells by High Throughput siRNA ScreeningR01DK082498 · NIDDK · RESEARCH INST OF FOX CHASE CAN CTR · PI KATZ, RICHARD ALAN · 2008 to 2010
$1.2M
GFP-Based Assays to Probe Transcriptional Controls(RMI)R21NS053666 · NINDS · INSTITUTE FOR CANCER RESEARCH · PI KATZ, RICHARD ALAN · 2005 to 2005
$211k
NCI NIH HHS CA06927NCI NIH HHS CA71515NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA071515NIAID NIH HHS R01 AI040385NIDDK NIH HHS DK082498NIDDK NIH HHS R01 DK082498NINDS NIH HHS NS053666
6 · The paper itself

Abstract

Epigenetic silencing is mediated by families of factors that place, remove, read, and transmit repressive histone and DNA methylation marks on chromatin. How the roles for these functionally diverse factors are specified and integrated is the subject of intense study. To address these questions, HeLa cells harboring epigenetically silent green fluorescent protein reporter genes were interrogated with a small interference RNA library targeting 200 predicted epigenetic regulators, including potential activators, silencers, chromatin remodelers, and ancillary factors. Using this approach, individual, or combinatorial requirements for specific epigenetic silencing factors could be detected by measuring green fluorescent protein reactivation after small interference RNA-based factor knockdown. In our analyses, we identified a specific subset of 15 epigenetic factors that are candidates for participation in a functional epigenetic silencing network in human cells. These factors include histone deacetylase 1, de novo DNA methyltransferase 3A, components of the polycomb PRC1 complex (RING1 and HPH2), and the histone lysine methyltransferases KMT1E and KMT5C. Roles were also detected for two TRIM protein family members, the cohesin component Rad21, and the histone chaperone CHAF1A (CAF-1 p150). Remarkably, combinatorial knockdown of factors was not required for reactivation, indicating little functional redundancy. Consistent with this interpretation, knockdown of either KMT1E or CHAF1A resulted in a loss of multiple histone-repressive marks and concomitant gain of activation marks on the promoter during reactivation. These results reveal how functionally diverse factors may cooperate to maintain gene silencing during normal development or in disease. Furthermore, the findings suggest an avenue for discovery of new targets for epigenetic therapies.

Indexed as

Gene SilencingAzacitidineCell SeparationChromatin Assembly Factor-1Clone CellsCytomegalovirusDNA Methyltransferase 3AGene Knockdown TechniquesGenes, ReporterGreen Fluorescent ProteinsHeLa CellsHigh-Throughput Screening AssaysHistonesHumansModels, GeneticNuclear ProteinsAzacitidineChromatin Assembly Factor-1CNOT8 protein, humanDNA Methyltransferase 3ADNMT3A protein, humanGreen Fluorescent ProteinsHistonesNuclear ProteinsRepressor ProteinsRNA, Small InterferingTranscription Factors

Identifiers

PMID19880521
PMCPMC2804189
OpenAlexW2066121337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.